Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Knowing when to revise your retirement strategy is key to staying on track. Learn the indicators that signal it's time for an adjustment.
21,255 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
As quantum tech hits the investing stage, two very different bets stand out: IonQ Quantum Computing Inc. and Quantum ...
ExxonMobil is not just drilling and refining anymore. This article explores how the company might evolve toward a bro...
Greg Abel, two months into his role as Berkshire Hathaway CEO, commits to using his after-tax salary to buy Berkshire...
Dell Technologies reports a 10% decline in global staff for the third consecutive year, trimming roughly 11,000 jobs ...
Chubb CEO Evan Greenberg releases a 25-page shareholder letter detailing strategic views on AI, China, and democracy’...
MercadoLibre reports a robust Q1 2026 with revenue rising sharply, even as margins compress. Analysts increasingly vi...
Nvidia revealed a next-gen PC chip lineup highlighted by AI efficiency, excluding Apple from key partnerships and pro...
A new crypto ETF offering 2x daily exposure to a Bitcoin strategy has collapsed, leaving early investors with severe ...
Pump.fun has unveiled a record-setting compensation package for its Chief Legal Officer, signaling a competitive push...
From a kitchen studio to a coveted CEO audience, this profile traces how David Senra built podcast influence by leani...
The YieldMax COIN Option Income Strategy ETF, ticker CONY, endured a steep 56.25% decline in the latest year, with di...